GANX EPS Estimates
Gain Therapeutics, Inc.
$1.26
-$0.03(-2.33%)
--
Overall
--
Value
--
Tech
--
Quality
Market Cap
--
Volume
640.96K
52W Range
$1.24 - $4.34
Target Price
--
GANX EPS estimates for Gain Therapeutics, Inc.. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
GANX EPS Estimates
- EPS growth, 3-year
- +25.58%
| Fiscal year | EPS |
|---|---|
| 2025 | $-0.61 |
| 2024 | $-0.89 |
| 2023 | $-1.71 |
| 2022 | $-1.48 |
| 2021 | $-1.37 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | GANX | $1.26 | -2.3% | 640.96K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |